Xcout Intel
iQure Pharma Inc. competitors & alternatives
The 12 closest competitors and alternatives to iQure Pharma Inc. — ranked by similarity to what iQure Pharma Inc. actually does, not by market-cap band.
Subscribe to see iQure Pharma Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About iQure Pharma Inc.
iQure Pharma Inc. is a pharmaceutical manufacturing and development company located in Princeton, New Jersey, focused on discovering treatments to restore glutamate balance in central nervous system disorders.
iQure Pharma Inc. at a glance
iQure Pharma Inc. is a company headquartered in United States. It has raised at least $8.4M across the 6 funding rounds on record. Its most recent funding round raised $650,000 in May 2026. Xcout tracks 12 named people at iQure Pharma Inc., including Pawel Zolnierczyk (President, CEO).
iQure Pharma Inc. leadership
- Pawel ZolnierczykPresident, CEO
- Henk de WildeChief Operating Officer and R&D Director
- Dr. Art Wamil, MDChief Medical Officer
- Prof. Dr Krzysztof KaminskiChief Scientific Officer
- Pawel ZolnierczykCo-founder & Chief Executive Officer
- Pawel ZolnierczykExecutive Officer
6 more named people on record for iQure Pharma Inc., with roles, board committees and tenure — see the full roster →
iQure Pharma Inc. funding rounds
At least $8.4M raised across the 6 rounds on record. The 5 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $650,000 | — | |
| SEC Form D filing | $2.8M | — | |
| SEC Form D filing | $1.4M | — | |
| SEC Form D filing | $220,000 | — | |
| Series A | $1.8M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent iQure Pharma Inc. news
- FundingPrivate placement (Form D)
Top 12 iQure Pharma Inc. competitors
Ranked by semantic similarity — how close each company is to iQure Pharma Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Close match by what they do
Cortex Pharmaceuticals, Inc. was a U.S. biopharmaceutical company focused on developing ampakine compounds and other glutamate-receptor modulators for central nervous system disorders. Its intended beneficiaries were patients with conditions such as cognitive impairment, depression, and other neurological or psychiatric disorders, rather than a general consumer market.
Close match by what they do
Zena Therapeutics Inc. is a privately held, innovative drug discovery and pharmaceutical company headquartered in Princeton, New Jersey.
Close match by what they do
CereSpir Inc. is a privately held, science-driven pharmaceutical company headquartered in New York with an innovative approach to treating central nervous system disorders.
Close match by what they do
EIP Pharma, Inc. is a privately held clinical-stage biotechnology company headquartered in Boston, Massachusetts. The company focuses on developing therapeutics for central nervous system (CNS) disorders.
Close match by what they do
Eleison Pharmaceuticals Inc. is a pharmaceutical company originally organized as a Delaware corporation in 2009 and headquartered in Princeton, New Jersey.
Healthcare
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that develops therapeutics for central nervous system disorders. Its pipeline focuses on treating conditions such as suicidal depression, suicidal bipolar depression, and post-traumatic stress disorder. The company utilizes a proprietary NMDA platform for its therapeutic developments.
Close match by what they do
Conjupro Biotherapeutics, Inc. is headquartered in Princeton, New Jersey, and focuses on pre-clinical and clinical pharmaceutical research and development.
Close match by what they do
NeuroRx, Inc. is a clinical-stage, small molecule pharmaceutical company headquartered in Radnor, Pennsylvania. The company focuses on developing novel therapeutics and advanced medical treatments.
Close match by what they do
Neumentum, Inc. is a pharmaceutical company with its principal place of business in Morristown, New Jersey, dedicated to developing non-opioid treatments for pain management.
Close match by what they do
Neuraptive Therapeutics, Inc. is a leading biopharmaceutical company headquartered in Chesterbrook in the Philadelphia suburbs of Pennsylvania.
Close match by what they do
Naurex was a biopharmaceutical company that developed novel therapeutics targeting the NMDA receptor, including the antidepressant candidate GLYX-13 (rapastinel). It was acquired by Allergan in 2015, with its research programs incorporated into Allergan’s neuroscience pipeline.
Pharmaceuticals
Otsuka America Pharmaceutical, Inc. is a healthcare and pharmaceutical company headquartered in Princeton, New Jersey, operating within the United States.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of iQure Pharma Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for iQure Pharma Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →